Aprogen Biologics Amends CB Issuance Terms
에이프로젠바이오로직스
003060
Signal Score
Historical Avg Return (5d)
+0.26%
Data Coverage
100%n=2414
Risk-adjusted indicator based on 2414 historical DART filings. For informational purposes only — not investment advice.
Financial Impact
NEUTRAL
Key Numbers
- • Initial Conversion Price: 2,353 KRW/Share
- • Minimum Adjustment Price: 1,648 KRW/Share
- • First Put Option Date: January 1, 2028
- • First Put Option Rate: 103.0760%
AI Analysis Summary
Aprogen Biologics Inc. has amended its Material Fact Report regarding the issuance of convertible bonds. The initial conversion price is confirmed at 2,353 KRW per share, with a minimum adjustment price of 1,648 KRW. The amendment clarifies the finalization of these prices and details the put option terms for bondholders, with the first exercise date on January 1, 2028, at a rate of 103.0760%. This update provides clarity on the CB terms but does not introduce new financial figures that would significantly alter the initial dilution impact.
Track Korean Market Signals — Free
Sign up free to access live disclosures, AI analysis, and event filters.
Public Beta · No credit card required
This content is for informational purposes only and does not constitute investment advice. Past signal patterns do not guarantee future results. All data is sourced from public DART filings.